This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
BNO Overzicht aandelen
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 0/6 |
Bionomics Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | AU$0.01 |
| 52 Week Hoogtepunt | AU$0.074 |
| 52 Week Laag | AU$0.009 |
| Bèta | 2.13 |
| 11 maand verandering | -16.67% |
| 3 maanden verandering | -52.38% |
| 1 Jaar Verandering | -81.13% |
| 33 jaar verandering | -92.86% |
| 5 jaar verandering | -98.10% |
| Verandering sinds IPO | -98.48% |
Recent nieuws en updates
Recent updates
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Jun 14
Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?
Feb 23Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Sep 14Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth
Nov 15Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?
Dec 30Rendement voor aandeelhouders
| BNO | AU Biotechs | AU Markt | |
|---|---|---|---|
| 7D | 0% | -2.6% | -2.0% |
| 1Y | -81.1% | 28.7% | 20.0% |
Rendement versus industrie: BNO underperformed the Australian Biotechs industry which returned -9.1% over the past year.
Rendement versus markt: BNO underperformed the Australian Market which returned 1.8% over the past year.
Prijsvolatiliteit
| BNO volatility | |
|---|---|
| BNO Average Weekly Movement | 24.4% |
| Biotechs Industry Average Movement | 10.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.6% |
Stabiele aandelenkoers: BNO's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: BNO's weekly volatility has increased from 18% to 24% over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1996 | n/a | Spyros Papapetropoulos | www.bionomics.com.au |
Bionomics Limited Samenvatting
| BNO fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | AU$14.69m |
| Inkomsten(TTM) | -AU$24.91m |
| Inkomsten(TTM) | AU$6.02m |
2.4x
P/S-verhouding-0.6x
Koers/WinstverhoudingIs BNO overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| BNO resultatenrekening (TTM) | |
|---|---|
| Inkomsten | AU$6.02m |
| Kosten van inkomsten | AU$19.80m |
| Brutowinst | -AU$13.79m |
| Overige uitgaven | AU$11.13m |
| Inkomsten | -AU$24.91m |
Laatst gerapporteerde inkomsten
Dec 31, 2022
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.017 |
| Brutomarge | -229.04% |
| Nettowinstmarge | -413.94% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde BNO op de lange termijn?
Bekijk historische prestaties en vergelijking